Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

INTRODUCTION: This study describes the frequency of prescription claims for drugs that may interact with Janus kinase (JAK) inhibitors among adult patients with rheumatoid arthritis (RA) in a large US claims database. METHODS: This observational, retrospective, cross-sectional study of the IBM(®) Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Walton, Alison, Paik, Jim, Quebe, Amanda, Kannowski, Carol L., Choong, Casey, Anderson, Seth, Owensby, Justin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991043/
https://www.ncbi.nlm.nih.gov/pubmed/33484433
http://dx.doi.org/10.1007/s40744-020-00275-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991043/
https://www.ncbi.nlm.nih.gov/pubmed/33484433
http://dx.doi.org/10.1007/s40744-020-00275-8

Ejemplares similares